Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IHH Healthcare BhdXKLS:5225 -0.85%88 EV-to-EBITDA is 13.50 as of Aug. 14, 2026, which is 14% below its 10-year median of 15.74. GuruFocus rates XKLS:5225 with a GF Score™ of 88/100 and a GF Value™ of RM8.20 (Fairly Valued). The stock has 11 warning signs investors should review. Among 511 Healthcare Providers & Services companies, IHH Healthcare Bhd ranks worse than 61.25% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, IHH Healthcare Bhd's enterprise value is RM88,901 Mil.
IHH Healthcare Bhd's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was RM6,584 Mil. Therefore, IHH Healthcare Bhd's EV-to-EBITDA for today is 13.50.
The historical rank and industry rank for IHH Healthcare Bhd's EV-to-EBITDA or its related term are showing as below:
XKLS:5225'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.16 Med: 15.74 Max: 36.83
Current: 13.51
During the past 13 years, the highest EV-to-EBITDA of IHH Healthcare Bhd was 36.83. The lowest was 10.16. And the median was 15.74.
XKLS:5225's EV-to-EBITDA is ranked worse than 61.25% of 511
companies
in the Healthcare Providers & Services industry
Industry Median: 10.76
vs XKLS:5225: 13.51
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
IHH Healthcare Bhd (XKLS:5225) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
IHH Healthcare Bhd's PE Ratio (TTM) for today is calculated as:
IHH Healthcare Bhd's share price for today is RM8.20.
IHH Healthcare Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.240.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for IHH Healthcare Bhd's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:5225 vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, IHH Healthcare Bhd's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IHH Healthcare Bhd EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, IHH Healthcare Bhd's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where IHH Healthcare Bhd's EV-to-EBITDA falls into.
IHH Healthcare Bhd's current Enterprise Value is RM88,901 Mil.
IHH Healthcare Bhd's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM6,584 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IHH Healthcare Bhd (XKLS:5225) has a EV-to-EBITDA of 13.50 as of Aug. 14, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on IHH Healthcare Bhd. This is 14% below median its historical median of 15.74. Over the past decade, IHH Healthcare Bhd's EV-to-EBITDA has ranged from 10.16 to 36.83. According to the industry distribution chart, IHH Healthcare Bhd ranks #313 out of 511 companies in the Healthcare Providers & Services industry, placing it in the top 61.3%.
Is IHH Healthcare Bhd's EV-to-EBITDA too high?
IHH Healthcare Bhd's current EV-to-EBITDA of 13.50 is 14% below median its 10-year median of 15.74. Over the past 10 years, this metric has ranged from a low of 10.16 to a high of 36.83. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.76. IHH Healthcare Bhd's value of 13.50 is 25.5% above this industry median. Based on the distribution chart, IHH Healthcare Bhd ranks #313 out of 511 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, IHH Healthcare Bhd has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IHH Healthcare Bhd's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, IHH Healthcare Bhd ranks #313 out of 511 companies for EV-to-EBITDA. This places IHH Healthcare Bhd in the lower half of its industry. The industry median EV-to-EBITDA is 10.76. IHH Healthcare Bhd's value of 13.50 is 25.5% above this benchmark. Historically, IHH Healthcare Bhd's own EV-to-EBITDA has ranged from 10.16 to 36.83 over the past decade. While the company's 10-year median is 15.74 vs. the industry median of 10.76, IHH Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.76, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IHH Healthcare Bhd's current EV-to-EBITDA of 13.50 is 25.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on IHH Healthcare Bhd. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IHH Healthcare Bhd's current EV-to-EBITDA is 13.50, which is 14% below median its own 10-year median of 15.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IHH Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, IHH Healthcare Bhd (XKLS:5225) is currently considered Fairly Valued. The stock's GF Value™ is RM8.20, compared to a current price of RM8.20 — trading right at its estimated fair value. The current EV-to-EBITDA is 13.50, which is 14% below median its 10-year median of 15.74 and 25.5% above the Healthcare Providers & Services industry median of 10.76. IHH Healthcare Bhd's overall GF Score™ is 88/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For IHH Healthcare Bhd (XKLS:5225), the current EV-to-EBITDA is 13.50 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IHH Healthcare Bhd (XKLS:5225) Overvalued in 2026?
Based on GuruFocus' analysis, IHH Healthcare Bhd stock appears to be undervalued.
The current stock price of RM8.20 is trading 0% below its estimated GF Value™ of RM8.20.
GuruFocus considers IHH Healthcare Bhd to be Fairly Valued.
Key valuation signals for XKLS:5225:
EV-to-EBITDA: 13.50 (14% below median its 10-year median of 15.74)
GF Value™: RM8.20 vs. price of RM8.20 (0% below fair value)
Industry Position: 25.5% above the Healthcare Providers & Services median (#313 of 511)
No single metric tells the full story. See the XKLS:5225 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IHH Healthcare Bhd is an investment holding company. Through its subsidiaries, it is a healthcare services provider that operates a network of hospitals. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The company's reportable segments include Healthcare services, Laboratories services, and Management fees. The majority of its revenue is generated from the Healthcare services segment, which relates to contracts with patients in which performance obligations are to provide healthcare services. Geographically, the company derives maximum revenue from Turkiye and Europe, followed by Singapore, Malaysia, India, Greater China, and Others.
88GF Score
Get the complete analysis for XKLS:5225
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5225 has been successfully added to your 
